Repligen Corporation - Common Stock (NQ:RGEN)

144.99 -0.24 (-0.17%)

Streaming Delayed Price Updated: 2:30 PM EDT, Jun 26, 2026 Add to My Watchlist

Price and Volume

Volume	634,587
Open	143.98
Bid (Size)	144.80 (200)
Ask (Size)	145.18 (200)
Prev. Close	145.23
Today's Range	143.98 - 146.82
52wk Range	100.99 - 175.77
Shares Outstanding	55,679,964
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 High-Flying Stocks on Our Watchlist and 1 We Find Risky

June 25, 2026

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...

Via StockStory

2 Profitable Stocks on Our Watchlist and 1 Facing Challenges

June 19, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

Performance

YTD	-11.8%	-11.8%
1 Month	+25.9%	+25.9%
3 Month	+26.7%	+26.7%
6 Month	-12.8%	-12.8%
1 Year	+16.9%	+16.9%

More News

3 Out-of-Favor Stocks We Keep Off Our Radar

May 22, 2026

Via StockStory

Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks

May 18, 2026

Via StockStory

Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss ↗

May 05, 2026

Via Chartmill

Why Repligen (RGEN) Stock Is Trading Up Today

May 15, 2026

Via StockStory

1 Growth Stock with Explosive Upside and 2 Facing Headwinds

May 15, 2026

Via StockStory

Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

May 13, 2026

Via StockStory

5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call

May 12, 2026

Via StockStory

3 Small-Cap Stocks We Steer Clear Of

May 12, 2026

Via StockStory

Repligen (RGEN) Shares Skyrocket, What You Need To Know

May 05, 2026

Via StockStory

Repligen (RGEN) Q1 2026 Earnings Call Transcript ↗

May 05, 2026

Via The Motley Fool

Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates

May 05, 2026

Via StockStory

Repligen (RGEN) Q1 Earnings Report Preview: What To Look For

May 03, 2026

Via StockStory

Why Repligen (RGEN) Shares Are Plunging Today

April 22, 2026

Via StockStory

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

April 17, 2026

Via StockStory

1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Avoid

April 16, 2026

Via StockStory

1 Cash-Producing Stock Worth Your Attention and 2 We Avoid

April 14, 2026

Via StockStory

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

March 27, 2026

Via StockStory

1 High-Flying Stock with Solid Fundamentals and 2 We Avoid

March 24, 2026

Via StockStory

1 Cash-Heavy Stock to Target This Week and 2 We Question

March 19, 2026

Via StockStory

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

March 15, 2026

Via StockStory

2 Growth Stocks Set to Flourishand 1 We Turn Down

March 13, 2026

Via StockStory

3 Profitable Stocks We Keep Off Our Radar

March 10, 2026

Via StockStory

Brown Capital Dumps 190,000 AppFolio Shares Worth $45.1 Million ↗

March 06, 2026

Via The Motley Fool

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?

Yes, Repligen Corporation - Common Stock is publicly traded.

What exchange does Repligen Corporation - Common Stock trade on?

Repligen Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Repligen Corporation - Common Stock?

The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market

What is the current price of Repligen Corporation - Common Stock?

The current price of Repligen Corporation - Common Stock is 144.99

When was Repligen Corporation - Common Stock last traded?

The last trade of Repligen Corporation - Common Stock was at 06/26/26 02:30 PM ET

What is the market capitalization of Repligen Corporation - Common Stock?

The market capitalization of Repligen Corporation - Common Stock is 8.07B

How many shares of Repligen Corporation - Common Stock are outstanding?

Repligen Corporation - Common Stock has 8B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.